In the present study, we report on the full range of physical diseases acquired by survivors of Hodgkin lymphoma diagnosed in adolescence or young adulthood. In a Danish nationwide population-based cohort study, 1768 five-year survivors of Hodgkin lymphoma diagnosed at ages 15–39 years during 1943-2004 and 228,447 comparison subjects matched to survivors on age and year of birth were included. Hospital discharge diagnoses and bed-days during 1977-2010 were obtained from the Danish Patient Register for 145 specific disease categories gathered in 14 main diagnostic groups. The analysis was conducted separately on three sub-cohorts of survivors, i.e. survivors diagnosed 1943-1976 for whom we had no information on re-hospitalisation for Hodgkin...
Background: Cancer is the most common cause of disease-related death in children, adolescents, and y...
Hodgkin lymphoma (HL) is a heterogeneous condition varying from engaging one single lymph node site ...
PURPOSE: Estimates of short- and long-term survival for young patients with classic Hodgkin lymphoma...
The burden of late effects among Hodgkin lymphoma (HL) survivors treated according to contemporary p...
BackgroundSurvivors of childhood cancer are at increased risk for a wide range of late effects. Howe...
Estimates of short- and long-term survival for young patients with classic Hodgkin lymphoma (cHL) ar...
Background: Survivors of childhood cancer are at increased risk for a wide range of late effects. Ho...
<div><p>Background</p><p>Survivors of childhood cancer are at increased risk for a wide range of lat...
Background: Survivors of childhood acute lymphoblastic leukemia (ALL) may be at increased long-term ...
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and...
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and...
Trends in Hodgkin lymphoma (HL) survival among patients treated outside of clinical trials provide r...
Background: Survivors of Hodgkin lymphoma (HL) are at risk of developing non-Hodgkin lymphoma (NHL) ...
Background: Survivors of Hodgkin lymphoma (HL) are at risk of developing non-Hodgkin lymphoma (NHL) ...
Background: Survivors of Hodgkin lymphoma (HL) are at risk of developing non-Hodgkin lymphoma (NHL) ...
Background: Cancer is the most common cause of disease-related death in children, adolescents, and y...
Hodgkin lymphoma (HL) is a heterogeneous condition varying from engaging one single lymph node site ...
PURPOSE: Estimates of short- and long-term survival for young patients with classic Hodgkin lymphoma...
The burden of late effects among Hodgkin lymphoma (HL) survivors treated according to contemporary p...
BackgroundSurvivors of childhood cancer are at increased risk for a wide range of late effects. Howe...
Estimates of short- and long-term survival for young patients with classic Hodgkin lymphoma (cHL) ar...
Background: Survivors of childhood cancer are at increased risk for a wide range of late effects. Ho...
<div><p>Background</p><p>Survivors of childhood cancer are at increased risk for a wide range of lat...
Background: Survivors of childhood acute lymphoblastic leukemia (ALL) may be at increased long-term ...
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and...
Population-based studies that assess long-term patterns of incidence, major aspects of treatment and...
Trends in Hodgkin lymphoma (HL) survival among patients treated outside of clinical trials provide r...
Background: Survivors of Hodgkin lymphoma (HL) are at risk of developing non-Hodgkin lymphoma (NHL) ...
Background: Survivors of Hodgkin lymphoma (HL) are at risk of developing non-Hodgkin lymphoma (NHL) ...
Background: Survivors of Hodgkin lymphoma (HL) are at risk of developing non-Hodgkin lymphoma (NHL) ...
Background: Cancer is the most common cause of disease-related death in children, adolescents, and y...
Hodgkin lymphoma (HL) is a heterogeneous condition varying from engaging one single lymph node site ...
PURPOSE: Estimates of short- and long-term survival for young patients with classic Hodgkin lymphoma...